1. Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy;
2. Genentech, Inc., South San Francisco, California;
3. Department of Medicine V, LMU University Hospital, LMU Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research, Munich, Germany;
4. Clinical Research Center, NHO Kinki Chuo Chest Medical Center, Osaka, Japan;
5. Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia;
6. National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon, National Research Institute for Agriculture, Food and the Environment, European Reference Network for Rare Respiratory Diseases, Lyon, France;
7. Imperial NIHR Biomedical Research Centre, National Heart and Lung Institute, Imperial College London, London, United Kingdom;
8. Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, Virginia;
9. University of Washington Medical Center, Seattle, Washington;
10. Roche Products Ltd., Welwyn Garden City, United Kingdom; and
11. Weill Cornell Medical College, New York–Presbyterian Hospital, New York, New York